Clinical trial
Comparative Analysis of Two Therapeutic Strategies: "Early Switch" Versus "Therapeutic Intensification" in Patients With Spondyloarthritis Treated With Anti-tnf Biologics, in Case of Secondary Treatment Failure Suspicion.
NCT01971918 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Analysis of Two Therapeutic Strategies: "Early Switch" Versus "Therapeutic Intensification" in Patients With Spondyloarthritis Treated With Anti-tnf Biologics, in Case of Secondary Treatment Failure Suspicion.
- Lead sponsor
- University Hospital, Rouen
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- May 31, 2014
- Completion date
- April 30, 2017
- Enrollment
- 8 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
spondyloarthritis